🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
The primary goal is to prospectively estimate the median PFS of African Ame...
Status
Completed
Location
Tulane University
Start Date
2017-07-10
Trial ID
NCT03098836
Treatments Being Tested
This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Status
Completed
Location
Istituto Giannina Gaslini
Start Date
2006-05-31
Trial ID
NCT00323960
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2003-11
Trial ID
NCT00059839
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested